Icon

VIGAFYDE - (100MG/1ML)

VIGABATRIN None
100MG/1ML
Less Than $1000 mn
None None
None None
None None
VIGAFYDE is indicated as monotherapy for the treatment of infantile spasms in pediatric patients 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss.
Yes
VIGAFYDE Patent 1 Patent 2
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.